Quick Answer
BioAtla, Inc. reported Operating Income Loss of -$59.31 million for the year ending 2025.
- BioAtla, Inc. showed an increase of +19.8% in Operating Income Loss from 2024 to 2025.
- This data is from BioAtla, Inc.'s annual report (Form 10-K), filed with the SEC on March 31, 2026.
- XBRL data for this metric is available from 2019 to 2025 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 7 years of available data (2019 to 2025), BioAtla, Inc.'s Operating Income Loss has declined by 109.8%.
- Historical annual values: Fiscal year 2025: -$59.31 million | Fiscal year 2024: -$73.94 million | Fiscal year 2023: -$129.69 million | Fiscal year 2022: -$108.14 million | Fiscal year 2021: -$96.44 million | Fiscal year 2020: -$30.10 million | Fiscal year 2019: -$28.27 million.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: